{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2013:HHV2DJIGUCFFG3P2GSZ22WPTSF","short_pith_number":"pith:HHV2DJIG","schema_version":"1.0","canonical_sha256":"39eba1a506a08a536dfa34b3ad59f39157bf71264a9b7232c84cb5f32209a646","source":{"kind":"arxiv","id":"1303.2803","version":2},"attestation_state":"computed","paper":{"title":"Explaining temporal trends in annualized relapse rates in placebo groups of randomized controlled trials in relapsing multiple sclerosis: systematic review and meta-regression","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Christian R\\\"over, Richard Nicholas, Sebastian Straube, Simon M. Steinvorth, Simon Schneider, Tim Friede","submitted_at":"2013-03-12T08:31:19Z","abstract_excerpt":"Background: Recent studies have shown a decrease in annualised relapse rates (ARRs) in placebo groups of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS).\n  Methods: We conducted a systematic literature search of RCTs in RMS. Data on eligibility criteria and baseline characteristics were extracted and tested for significant trends over time. A meta-regression was conducted to estimate their contribution to the decrease of trial ARRs over time.\n  Results: We identified 56 studies. Patient age at baseline (p < 0.001), mean duration of multiple sclerosis (MS) at baseline "},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1303.2803","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2013-03-12T08:31:19Z","cross_cats_sorted":[],"title_canon_sha256":"08faf0cb8263c47f89b83136986af4e8d0cd1dc6d779942a6831bb7f98664cc0","abstract_canon_sha256":"39ddcdb62139a31a8800153cb724186afd8c685b63d4d8f47a53c1d0e2087897"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T02:56:12.769094Z","signature_b64":"FnFZnJy4AsuXcHi0zYbLdGzT8T3MIU1iKsCbAzQUOhMegj9WbnOi9es/mdwggYYsTBYT0g/yDLFPJKHoMLpxDA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"39eba1a506a08a536dfa34b3ad59f39157bf71264a9b7232c84cb5f32209a646","last_reissued_at":"2026-05-18T02:56:12.768733Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T02:56:12.768733Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Explaining temporal trends in annualized relapse rates in placebo groups of randomized controlled trials in relapsing multiple sclerosis: systematic review and meta-regression","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Christian R\\\"over, Richard Nicholas, Sebastian Straube, Simon M. Steinvorth, Simon Schneider, Tim Friede","submitted_at":"2013-03-12T08:31:19Z","abstract_excerpt":"Background: Recent studies have shown a decrease in annualised relapse rates (ARRs) in placebo groups of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS).\n  Methods: We conducted a systematic literature search of RCTs in RMS. Data on eligibility criteria and baseline characteristics were extracted and tested for significant trends over time. A meta-regression was conducted to estimate their contribution to the decrease of trial ARRs over time.\n  Results: We identified 56 studies. Patient age at baseline (p < 0.001), mean duration of multiple sclerosis (MS) at baseline "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1303.2803","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1303.2803","created_at":"2026-05-18T02:56:12.768793+00:00"},{"alias_kind":"arxiv_version","alias_value":"1303.2803v2","created_at":"2026-05-18T02:56:12.768793+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1303.2803","created_at":"2026-05-18T02:56:12.768793+00:00"},{"alias_kind":"pith_short_12","alias_value":"HHV2DJIGUCFF","created_at":"2026-05-18T12:27:46.883200+00:00"},{"alias_kind":"pith_short_16","alias_value":"HHV2DJIGUCFFG3P2","created_at":"2026-05-18T12:27:46.883200+00:00"},{"alias_kind":"pith_short_8","alias_value":"HHV2DJIG","created_at":"2026-05-18T12:27:46.883200+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF","json":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF.json","graph_json":"https://pith.science/api/pith-number/HHV2DJIGUCFFG3P2GSZ22WPTSF/graph.json","events_json":"https://pith.science/api/pith-number/HHV2DJIGUCFFG3P2GSZ22WPTSF/events.json","paper":"https://pith.science/paper/HHV2DJIG"},"agent_actions":{"view_html":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF","download_json":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF.json","view_paper":"https://pith.science/paper/HHV2DJIG","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1303.2803&json=true","fetch_graph":"https://pith.science/api/pith-number/HHV2DJIGUCFFG3P2GSZ22WPTSF/graph.json","fetch_events":"https://pith.science/api/pith-number/HHV2DJIGUCFFG3P2GSZ22WPTSF/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF/action/timestamp_anchor","attest_storage":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF/action/storage_attestation","attest_author":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF/action/author_attestation","sign_citation":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF/action/citation_signature","submit_replication":"https://pith.science/pith/HHV2DJIGUCFFG3P2GSZ22WPTSF/action/replication_record"}},"created_at":"2026-05-18T02:56:12.768793+00:00","updated_at":"2026-05-18T02:56:12.768793+00:00"}